Cargando…
Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report
RATIONALE: Papillary renal cell carcinoma (PRCC) accounts for about 15% to 20% of renal cell carcinoma and is histologically distinguished in type I and type II. The last one is associated with poorer prognosis. Treatment options for PRCC patients are surgery, immunotherapy, revolutionized by Nivolu...
Autores principales: | Naglieri, Emanuele, Niccoli Asabella, Artor, Nappi, Anna Giulia, Carella, Claudia, Ferrari, Cristina, Rubini, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922556/ https://www.ncbi.nlm.nih.gov/pubmed/31852068 http://dx.doi.org/10.1097/MD.0000000000018093 |
Ejemplares similares
-
(18)F-FDG PET/CT Role in Staging of Gastric Carcinomas: Comparison with Conventional Contrast Enhancement Computed Tomography
por: Altini, Corinna, et al.
Publicado: (2015) -
Pediatric Hodgkin Lymphoma: Predictive value of interim (18)F-FDG PET/CT in therapy response assessment
por: Ferrari, Cristina, et al.
Publicado: (2017) -
Heterogeneous Response to Immunotherapy in a Patient with Tonsillar Squamous Cell Carcinoma Assessed by (18)F-FDG PET/CT
por: Niccoli Asabella, Artor, et al.
Publicado: (2021) -
Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives
por: Niccoli Asabella, Artor, et al.
Publicado: (2017) -
Early Evaluation of Immunotherapy Response in Lymphoma Patients by 18F-FDG PET/CT: A Literature Overview
por: Ferrari, Cristina, et al.
Publicado: (2021)